Clarify Health operates Atlas, the healthcare analytics platform with the industry’s most precise and actionable healthcare journey insights for providers, health plans, and life sciences companies. Atlas maps over 4 billion care journeys across more than 300 million individuals, drives 18 billion + AI-powered predictions, and delivers insights in cloud software, answering healthvare’s most complex business questions in an instant.

DEMECAN is the only independent German company that covers all manufacturing steps for medical cannabis – from cultivation, processing and storage – as well as wholesale, distribution and delivery to pharmacies all over Germany.

Diagnose Early provides commercializes methods for diagnosis of neurological diseases, cancer, and infectious diseases. Diagnose Early uses non-invasive breath-based tests. Clinical trial with Stanford University Hospital has recently developed a test / triage for level 2 in COVID, named D.E.C.A. – Diagnose Early Covid Acuity Test.

Elevian develops medicines that restore the regenerative capacity of the human body with the potential to treat and prevent many age-related diseases, based on a recombinant protein called growth differentiation factor 11 (rGDF11). Research is done at Harvard University. Elevian is currently in the preclinical phase for ischemic as well as hemorrhagic stroke recovery as well as in the discovery phase of various other indications.

Elucida Oncology develops break-through ultra small CDot platform that enables precise tumor targeting, deep tumor penetration and better tumor killing efficacity. Enables novel therapeutics that clear rapidly and efficiently from the body, reducing the potential for off- target toxicities and resulting in an improved safety profile for patients. Also enables more precise surgery of tumors. Elucida is currently enrolling patients for its first phase 1 trial and is advancing numerous solid pre-clinical progams.

Genomelink is an everything store for your DNA: Additional analyses of Ancestry DNA, 23andme DNA, Heritage DNA not provided by the DNA testing labs.

Innovein develops a first of its kind replacement valve for veins.

Kangaroo Health operates an AI assisted virtual care program that offers disease state monitoring and personalized remote health coaching for a variety of indications like hypertension, cardiovascular diseases and surgery. The tool offers weekly personalized coaching lessons, homebased health condition monitoring, AI based early risk flagging, daily interactive lessons and online peer groups.

Sensely is an avatar-based, empathy-driven conversational platform powered by trusted content from Mayo clinic and NHS content, designed to enhance member experience, elevate brand preference, influence behavior.

X-Vax develops vaccines against Herpes. The approach is based on a Herpes 2 virus genetically deleted for glycoprotein D (Delta-gD-2). Using this, disease caused by Herpes 1 and Herpes 2 viruses have been prevented in multiple pre-clinical models.

Zenflow develops a spring device that is designed to permanently hold back the growing prostate without damaging tissue and thereby treat benign prostatic hyperplasia. Clinical cases performed by top global urologists have shown a well-tolerated procedure with a low rate of side effects, fast recovery, and durable results of at least 2 years. The company is currently enrolling patients in clinical trials in Australia, New Zealand and Mexico.